{"id":2968,"date":"2021-09-06T10:31:45","date_gmt":"2021-09-06T10:31:45","guid":{"rendered":"https:\/\/dreleniloukianou.com\/publications\/"},"modified":"2021-09-22T06:58:36","modified_gmt":"2021-09-22T06:58:36","slug":"publications","status":"publish","type":"page","link":"https:\/\/www.dreleniloukianou.com\/el\/publications\/","title":{"rendered":"\u0394\u03b7\u03bc\u03bf\u03c3\u03b9\u03b5\u03cd\u03c3\u03b5\u03b9\u03c2"},"content":{"rendered":"

[vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
1<\/div>\n
\n

Molecular analysis of Cypriot families with aniridia reveals a novel PAX6 mutation<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Syrimis A, Nicolaou N, Alexandrou A, Papaevripidou I, Nicolaou M, Loukianou E<\/strong>, Sismani C,Malas S, Christophidou-Anastasiadou V, Tanteles GA<\/p>\n

Mol Med Rep. 2018 Aug;18(2):1623-1627[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
2<\/div>\n
\n

Aniridia due to a microdeletion affecting PAX6 regulatory enhancers: A case report and literature review.<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Syrimis \u0391 , Nicolaou \u039d, Alexandrou \u0391, Papaevripidou \u0399, Loukianou \u0395<\/strong>, Christophidou-Anastasiadou V, Malas S, Sismani C, Tanteles GA.<\/p>\n

J Genet 2018 Jun;97(2):555-562[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
3<\/div>\n
\n

Central serous chorioretinopathy associated with desmopressin nasal spray. Causality or unfortunate association.<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Kisma N, Loukianou E<\/strong>, Pal B<\/p>\n

Case Rep Ophthalmol. 2018 Feb 6; 9 (1) 120-125[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
4<\/div>\n
\n

Intravitreal Aflibercept in Recalcitrant Radiation Maculopathy due to External Beam Radiotherapy for Nasopharyngeal Cancer: A First Case Report.<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Loukianou E<\/strong>, Loukianou G.<\/p>\n

Case Rep Ophthalmol. 2017 Feb 2;8(1):87-90.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
5<\/div>\n
\n

Pseudotumor cerebri in a child with idiopathic growth hormone insufficiency two months after initiation of recombinant human growth hormone treatment.<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Loukianou E<\/strong>, Tasiopoulou A, Demosthenous C, Brouzas D.<\/p>\n

Case Rep Ophthalmol Med. 2016;2016:4756894.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
6<\/div>\n
\n

Clinical, anatomical and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Loukianou E<\/strong>, Brouzas D, Chatzistefanou K, Koutsandrea C.<\/p>\n

Int Ophthalmol. 2016 Feb; 36 (1):21-36[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
7<\/div>\n
\n

Novel GLI 3 mutation in the first reported Greek- Cypriot patient with Greig cephalopolysyndactyly syndrome.<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Tanteles G, Michaelidou S, Loukianou E<\/strong>, Christophidou-Anastasiadou V, Kleopa K.<\/p>\n

Clin Dysmorphol. 2015 Jul;24(3):102-5[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
8<\/div>\n
\n

Keratoconjuctivitis and periorbital edema due to Ecballium elaterium<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Brouzas D, Oanta M, Loukianou E<\/strong>, Moschos M.<\/p>\n

Case Rep Ophthalmol 2012 Jan;3 (1): 87-90[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
9<\/div>\n
\n

Photographic documentation of the evolution of an optic nerve head lesion in a patient with retinitis pigmentosa<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Loukianou E<\/strong><\/p>\n

Int Ophthalmol. 2011 Aug;31(4):321-3
\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
10<\/div>\n
\n

Sustained ocular hypertension following intravitreal injections of 0, 5 mg \/0, 05 ml ranibizumab<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Loukianou E<\/strong>, Brouzas D, Apostolopoulos M.<\/p>\n

Int Ophthalmol. 2011 Jun;31(3):211-3
\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
11<\/div>\n
\n

Ulnar neuropathy as a complication of retinal detachment surgery and face down positioning.<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Brouzas D, Gourgounis N, Davou S, Loukianou E , <\/strong>Georgalas I, Koutsandrea C.<\/p>\n

Case Rep Ophthalmol 2011;2(2): 243-245[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
12<\/div>\n
\n

Evolution of an astrocytic hamartoma of the optic nerve head in a patient with retinitis pigmentosa-Photographic documentation over 2 years of follow-up.<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Loukianou E<\/strong>, Kisma N, Pal B.<\/p>\n

Case Rep Ophthalmol 2011;2;2(1):45\u201349 .DOI: 10.1159\/000324037[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
13<\/div>\n
\n

Choroidal neovascularization due to punctate inner choroidopathy: long-term follow-up and review of literature.<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Brouzas D., Charakidas A., Rotsos T., M. Moschos, Loukianou H.<\/strong>, Koutsandrea C., Ladas I., Baltatzis S.<\/p>\n

Clin Ophthalmol. 2010 Aug 9; 4:871-6[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
14<\/div>\n
\n

Intravitreal bevacizumab for macular edema due to proton beam radiotherapy. Favourable results shown after eighteen months follow-up.<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Loukianou E.<\/strong>, Brouzas D., Georgopoulou E., Koutsandrea C., Apostolopoulos M.<\/p>\n

Ther Clin Risk Manag 2010 ; 25(6):249-252[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
15<\/div>\n
\n

Complete Resolution of a Giant Pigment Epithelial Detachment Secondary to Exudative Age-Related Macular Degeneration after a Single Intravitreal Ranibizumab (Lucentis) Injection: Results Documented by Optical Coherence Tomography<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Loukianou E<\/strong>, Kisma N, Hamilton R.<\/p>\n

Case Rep Ophthalmol 2010;1(2):110\u2013113[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
16<\/div>\n
\n

Intraocular triamcinolone acetonide for pseudophakic cystoid macular edema: optical coherence tomography and multifocal electroretinography study<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Koutsandrea C, Moschos MM, Brouzas D, Loukianou E, <\/strong>Apostolopoulos M, Moschos M.<\/p>\n

Retina 2007 Feb 27(2):159-164[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
17<\/div>\n
\n

Assessment of central serous chorioretinopathy by optical coherence tomography and multifocal electroretinography.<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Moschos M, Brouzas D, Koutsandrea C, Stefanos B, Loukianou E,<\/strong> Papantonis F, Moschos M.<\/p>\n

Ophthalmologica 2007; 221(5):292-8[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
18<\/div>\n
\n

Intravitreal use of Bevacizumab (Avastin) for choroidal neovascularisation due to ARMD: a preliminary multifocal-ERG and OCT study: Multifocal-ERG after use of bevacizumab in ARMD.<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Moschos MM, Brouzas D, Apostolopoulos M, Koutsandrea C, Loukianou E,<\/strong> Moschos M.<\/p>\n

Doc Ophthalmol 2007 Jan 114(1):37-44[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
19<\/div>\n
\n

Intraocular triamcinolone acetonide for macular edema due to CRVO.A multifocal ERG and OCT study<\/h2>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Moschos MM, Brouzas D, Loukianou E<\/strong>, Apostolopoulos M, Moschos M.<\/p>\n

Doc Ophthalmol.2007 Jan 114 (1):1-7[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text] 1 Molecular analysis of Cypriot families with aniridia reveals a novel PAX6 mutation [\/vc_column_text][vc_empty_space height=”26px”][vc_column_text rsclass=”clean”]Syrimis A, Nicolaou N, Alexandrou A, Papaevripidou I, Nicolaou M, Loukianou E, Sismani C,Malas S, Christophidou-Anastasiadou V, Tanteles GA Mol Med Rep. 2018 Aug;18(2):1623-1627[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator css=”.vc_custom_1630922675718{margin-top: 30px !important;margin-bottom: 30px !important;}”][\/vc_column][\/vc_row][vc_row rsclass=”clean” el_class=”section”][vc_column rsclass=”clean” el_class=”container”][vc_row_inner][vc_column_inner][vc_column_text] 2 Aniridia <\/p>\n

<\/path><\/svg>Read More “\u0394\u03b7\u03bc\u03bf\u03c3\u03b9\u03b5\u03cd\u03c3\u03b5\u03b9\u03c2”<\/span><\/path><\/svg><\/a><\/div>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2968","page","type-page","status-publish","hentry"],"yoast_head":"\n\u0394\u03b7\u03bc\u03bf\u03c3\u03b9\u03b5\u03cd\u03c3\u03b5\u03b9\u03c2 - Dr. Eleni Loukianou - Consultant Ophthalmic Surgeon<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\t\n